Introduction to Sodium Hyaluronate
Sodium hyaluronate has a history of nearly 80 years since its discovery. As early as 1934, Meyer and Palmer isolated a polymer containing uronic acid and hexosamine from the hyaloid body. Polysaccharide, named “히알루론산”. The word is a combination of “hyaloid” (투명한, glassy) 그리고 “uronic acid”, “Biochemical Noun” is translated as “히알루론산”, “Chinese Pharmacopoeia” and national drug standards are called “히알루론산” “. In a physiologically neutral environment, hyaluronic acid is a polyanion. ~ 안에 1985, Balazs et al. suggested using the term hyaluronan to name the substance uniformly. The reason is that the substance is essentially a carbohydrate and should be named according to its glycosaminoglycan naming rules, that is, the suffix an is used.
“Hyaluronan” has been widely used, covering any state of hyaluronic acid and its salts (hyaluronate), usually translated as “히알루론산”, abbreviated as HA. 현재, HA products with the drug standard are usually called “sodium hyaluronate injection”, and HA products with the drug standard are called medical sodium hyaluronate gel. As early as the late 1970s, the United States first developed the first product of this substance that could be used in human clinical practice. Since this product is used for ophthalmic microsurgery-cataract surgery, its main function is that clinicians act as ophthalmic microscopy Surgical pads are used as a temporary support for the operation space to facilitate the smooth implementation of the operation.
그러므로, they are approved and sold on the market. Subsequently, this product has come out in orthopedics and surgery, all of which are sold under the instrument number. 그러므로, the FDA in the United States recognized the substance as a medical device.